Peapack Gladstone Financial Corp Novartis Ag Transaction History

Peapack Gladstone Financial Corp

  • $6.89 Billion
  • Q4 2024

A detailed history of Peapack Gladstone Financial Corp transactions in Novartis Ag stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 24,642 shares of NVS stock, worth $2.76 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
24,642
Previous 25,157 2.05%
Holding current value
$2.76 Million
Previous $2.9 Million 17.13%
% of portfolio
0.03%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$96.78 - $117.18 $49,841 - $60,347
-515 Reduced 2.05%
24,642 $2.4 Million
Q3 2024

Nov 26, 2024
BUY
$106.13 - $120.89 $4,139 - $4,714
39 Added 0.16%
25,157 $2.9 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $41,749 - $48,423
-451 Reduced 1.76%
25,118 $2.67 Million
Q1 2024

May 10, 2024
SELL
$95.27 - $108.47 $88,124 - $100,334
-925 Reduced 3.49%
25,569 $2.47 Million
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $100,112 - $110,170
-1,085 Reduced 3.93%
26,494 $2.67 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $57,880 - $64,234
-611 Reduced 2.17%
27,579 $2.81 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $2,127 - $2,412
-23 Reduced 0.08%
28,190 $2.84 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $2.82 Million - $3.28 Million
-35,291 Reduced 55.57%
28,213 $2.59 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $146,189 - $179,026
-1,935 Reduced 2.96%
63,504 $5.76 Million
Q3 2022

Nov 10, 2022
BUY
$74.61 - $87.26 $213,832 - $250,087
2,866 Added 4.58%
65,439 $4.97 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $91,953 - $107,062
-1,142 Reduced 1.79%
62,573 $5.29 Million
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $957,074 - $1.08 Million
-11,947 Reduced 15.79%
63,715 $5.59 Million
Q4 2021

Feb 15, 2022
BUY
$79.7 - $88.13 $4,303 - $4,759
54 Added 0.07%
75,662 $6.62 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $8,750 - $10,179
-107 Reduced 0.14%
75,608 $6.18 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $131,184 - $144,896
-1,539 Reduced 1.99%
75,715 $6.91 Million
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $46,175 - $54,453
-553 Reduced 0.71%
77,254 $6.6 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $1.83 Million - $2.21 Million
-23,420 Reduced 23.14%
77,807 $7.35 Million
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $85,507 - $94,731
1,041 Added 1.04%
101,227 $8.8 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $940,568 - $1.06 Million
11,622 Added 13.12%
100,186 $8.75 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $2.43 Million - $3.4 Million
34,352 Added 63.37%
88,564 $7.3 Million
Q4 2019

Feb 14, 2020
BUY
$84.35 - $95.37 $35,595 - $40,246
422 Added 0.78%
54,212 $5.13 Million
Q3 2019

Nov 13, 2019
SELL
$85.54 - $94.26 $11,547 - $12,725
-135 Reduced 0.25%
53,790 $4.67 Million
Q2 2019

Aug 15, 2019
SELL
$75.4 - $92.8 $78,265 - $96,326
-1,038 Reduced 1.89%
53,925 $4.92 Million
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $2,560 - $2,929
34 Added 0.06%
54,963 $5.29 Million
Q4 2018

Feb 14, 2019
BUY
$73.66 - $82.02 $2.84 Million - $3.16 Million
38,564 Added 235.65%
54,929 $4.71 Million
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $174,378 - $201,705
2,605 Added 18.93%
16,365 $1.41 Million
Q2 2018

Aug 09, 2018
SELL
$64.91 - $73.36 $3,634 - $4,108
-56 Reduced 0.41%
13,760 $1.04 Million
Q1 2018

May 10, 2018
SELL
$70.39 - $84.15 $108,963 - $130,264
-1,548 Reduced 10.08%
13,816 $0
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $44,121 - $47,360
610 Added 4.13%
15,364 $0
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $38,997 - $40,644
-526 Reduced 3.44%
14,754 $0
Q2 2017

Aug 14, 2017
BUY
N/A
15,280
15,280 $0

Others Institutions Holding NVS

# of Institutions
1,477
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email